lipanthyl 200 micronised 200 mg harde caps.
viatris healthcare sa-nv - fenofibraat 200 mg - capsule, hard - 200 mg - fenofibraat 200 mg - fenofibrate
lipanthyl 267 micronised 267 mg harde caps.
viatris healthcare sa-nv - fenofibraat 267 mg - capsule, hard - 267 mg - fenofibraat 267 mg - fenofibrate
lipanthyl 67 micronised 67 mg harde caps.
viatris healthcare sa-nv - fenofibraat 67 mg - capsule, hard - 67 mg - fenofibraat 67 mg - fenofibrate
lipanthylnano 145 mg filmomh. tabl.
viatris healthcare sa-nv - fenofibraat 145 mg - filmomhulde tablet - 145 mg - fenofibraat 145 mg - fenofibrate
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate mylan
mylan ireland limited - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethylfumaraat teva 120 mg, harde maagsapresistente capsules
dimethylfumaraat 120 mg/stuk - maagsapresistente capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; crospovidon (e 1202) ; gelatine (e 441) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; magnesiumstearaat (e 470b) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak (e 904) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505) ; zwarte inkt